Latest Industry Insights
Industry Insight
Building Infinity™: How GeneDx Is Transforming Rare Disease Diagnosis
Families with rare diseases often wait years for answers. GeneDx’s AI-driven dataset, Infinity™, is changing that. In this interview, Dr. Bryan Dechario explains how decades of data are reshaping the future of genomic medicine.
Industry Insight
Improving Detection and Interpretation in Hereditary Cancer Testing
In this interview, Dr. Eleonora Juarez explains how Oxford Nanopore’s new Hereditary Cancer Panel could streamline testing, expand access and influence future best practices in hereditary cancer workflows.
Industry Insight
Inside Cambridge’s Collaborative Future: How journey Is Transforming the Lab Space Landscape
In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.
Industry Insight
Building the Next Generation of Genetic Medicines With LNPs
A recent milestone study used the LNP delivery system developed by Acuitas Therapeutics to treat a newborn with urea cycle disorder (UCD) successfully with a personalized CRISPR therapy. We spoke to Dr. Ying Tam, their CSO, to find out more.
Industry Insight
AI and Synthetic Biology: Balancing Innovation With Biosecurity
AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.
Industry Insight
New Partnership Will Probe the Connection Between Tau Protein and Alzheimer’s
Technology Networks spoke with Nautilus Biotechnology and the Allen Institute about their new agreement to advance Alzheimer’s research through proteoform analysis.
Industry Insight
Whole-Genome Sequencing Enables Rare Variant Discovery at Scale
Illumina’s Rami Mehio discusses the whole-genome sequencing of 490,640 UK Biobank participants with Molly Coddington for Technology Networks.
Industry Insight
Life Science Marketing: All You Need To Know
This article explores the unique characteristics and challenges of life sciences marketing, offering insights on how to achieve meaningful engagement with a highly specialized audience.
Industry Insight
Academic Origins Driving Impact in Epigenetic Diagnostics
An epigenetic analysis platform spun out of academia could address current issues with wider adoption of epigenetic profiling as a cancer diagnostic tool. Hear about the challenges, successes and importance of industry partners.
Industry Insight
ctDNA, CTCs and the Future of Liquid Biopsy
Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology is helping to overcome some of these issues and the future monitoring landscape.
Advertisement
